# Starling Oncology, Inc.: Form SCHEDULE 13D/A, filed May 15, 2026

- Company: [Starling Oncology, Inc.](/companies/stln.md) (CIK 1799191)
- Form: SCHEDULE 13D/A
- Filed: 2026-05-15
- Accepted by EDGAR: May 15, 2026, 16:30 ET
- Period: not reported
- Accession: 0001213900-26-057832
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1799191/000121390026057832/xslSCHEDULE_13D_X02/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1799191/000121390026057832/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1799191/000121390026057832/xslSCHEDULE_13D_X02/primary_doc.xml

Filed May 15, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-057832. Last ingested by Listed: Nov 15, 2026, 04:34 ET. No prices; not investment advice.